LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 91.27 | 84.90 | 1486 | 7420 | 0.2003 | 0.5586 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 91.27 | 84.90 | 6463 | 7420 | 0.8710 | 0.9576 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 92.98 | 84.90 | 324 | 7257 | 0.0446 | 0.2321 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 92.98 | 84.90 | 3327 | 7257 | 0.4584 | 0.7711 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 92.98 | 84.90 | 1731 | 7257 | 0.2385 | 0.5997 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 92.98 | 84.90 | 6704 | 7257 | 0.9237 | 0.9754 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 94.68 | 84.90 | 329 | 7000 | 0.0470 | 0.2371 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 94.68 | 84.90 | 3574 | 7000 | 0.5105 | 0.7996 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 94.68 | 84.90 | 1779 | 7000 | 0.2541 | 0.6128 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 94.68 | 84.90 | 6869 | 7000 | 0.9812 | 0.9941 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 2.66 | 84.90 | 503 | 285 | 1.7604 | 1.7625 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 2.66 | 84.90 | 586 | 285 | 2.0508 | 2.0143 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 4.36 | 84.90 | 551 | 322 | 1.7081 | 1.6410 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 4.36 | 84.90 | 625 | 322 | 1.9376 | 1.8196 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 6.06 | 84.90 | 609 | 365 | 1.6664 | 1.5489 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 6.06 | 84.90 | 690 | 365 | 1.8881 | 1.7046 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 7.77 | 84.90 | 629 | 411 | 1.5295 | 1.4105 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | G16 |